Yan Chen

发表

Long-term effects of baseline on-treatment platelet reactivity in patients with acute coronary syndrome and thrombocytopenia undergoing percutaneous coronary intervention

Xiaofang Tang, Ce Zhang, R. Gao, 2022, The Journal of international medical research.

Association of β-Blocker Therapy at Discharge with Clinical Outcomes after Acute Coronary Syndrome in Patients without Heart Failure

B. Xu, Jin-qing Yuan, Yuejin Yang, 2020, Cardiovascular therapeutics.

Does Baseline On-treatment Platelet Reactivity Impact Long-term Prognosis in Patients with Acute Coronary Syndrome and Thrombocytopenia Who Underwent Percutaneous Coronary Intervention?

B. Xu, Xiaofang Tang, Ce Zhang, 2021 .

Influence of Stent Length on Periprocedural Outcomes After Primary Percutaneous Coronary Intervention in Patients with ST Segment Elevation Myocardial Infarction

Yun-fan Wang, Yan Chen, Yanhui Gao, 2022, Clinical interventions in aging.

Plasma big endothelin-1 and stent thrombosis: An observational study in patients undergoing percutaneous coronary intervention in China.

Jing-jing Xu, S. Qiao, Jin-qing Yuan, 2017, Thrombosis research.

Stress hyperglycemia ratio and long‐term prognosis in patients with acute coronary syndrome: A multicenter, nationwide study

Jing-jing Xu, Yaling Han, Xiaozeng Wang, 2023, Journal of diabetes.

For patients with prior coronary artery bypass grafting and recurrent myocardial ischemia, percutaneous coronary intervention on bypass graft or native coronary artery?—A 5‐year follow‐up cohort study

T. Yang, Xiaofang Tang, Hai-bo Liu, 2023, Clinical cardiology.

Inverse Association of Lipoprotein(a) on Long-Term Bleeding Risk in Patients with Coronary Heart Disease: Insight from a Multicenter Cohort in Asia

Jing-jing Xu, Yaling Han, Xiaozeng Wang, 2022, Thrombosis and Haemostasis.

Prognostic significance of inflammation in patients with coronary artery disease at low residual inflammatory risk

Jing-jing Xu, Xiaofang Tang, Yi Yao, 2023, iScience.

Inflammation and Insulin Resistance in Diabetic Chronic Coronary Syndrome Patients

Jing-jing Xu, Yaling Han, Xiaozeng Wang, 2023, Nutrients.

Baseline high-sensitivity C-reactive protein and glycosylated hemoglobinA1c predict adverse outcomes in patients with chronic coronary syndromes undergoing percutaneous coronary intervention

Xiaofang Tang, Yi Yao, D. Yuan, 2023, Heliyon.

Renal function alters the association of lipoprotein(a) with cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a prospective cohort study

Jing-jing Xu, Xiaofang Tang, Ce Zhang, 2024, Clinical kidney journal.

Post-procedural elevated cardiac troponin I and the association with 5-year mortality in patients undergoing elective PCI

Jing-jing Xu, Lin Jiang, Ying Song, 2024, Heliyon.